Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

PubMed  Google Scholar 

Oliver AL. Lung cancer: epidemiology and screening. Surg Clin North Am. 2022;102(3):335–44.

Article  PubMed  Google Scholar 

US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for lung cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962–70.

Article  Google Scholar 

Bonney A, Malouf R, Marchal C, Manners D, Fong KM, Marshall HM, et al. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality. Cochrane Database Syst Rev. 2022;8(8):CD013829.

PubMed  Google Scholar 

Lancaster HL, Heuvelmans MA, Oudkerk M. Low-dose computed tomography lung cancer screening: clinical evidence and implementation research. J Intern Med. 2022;292(1):68–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33–8.

Article  PubMed  Google Scholar 

Mazzone PJ, Silvestri GA, Souter LH, Caverly TJ, Kanne JP, Katki HA, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2021;160(5):e427–94.

Article  PubMed  PubMed Central  Google Scholar 

Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107–17.

PubMed  PubMed Central  Google Scholar 

National Lung Screening Trial Research Team. Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol. 2019;14(10):1732–42.

Article  Google Scholar 

de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–13.

Article  PubMed  Google Scholar 

Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, et al. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(10):971–87.

Article  PubMed  Google Scholar 

Ren F, Fei Q, Qiu K, Zhang Y, Zhang H, Sun L. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation. J Exp Clin Cancer Res. 2024;43(1):96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quanyang W, Yao H, Sicong W, Linlin Q, Zewei Z, Donghui H, et al. Artificial intelligence in lung cancer screening: detection, classification, prediction, and prognosis. Cancer Med. 2024;13(7):e7140.

Article  PubMed  PubMed Central  Google Scholar 

Nunez ER, Ito Fukunaga M, Stevens GA, Yang JK, Reid SE, Spiegel JL, et al. Review of interventions that improve uptake of lung cancer screening: a cataloging of strategies that have been shown to work (or not). Chest. 2024;166(3):632–48.

Article  PubMed  PubMed Central  Google Scholar 

Symvoulakis EK, Bouloukaki I, Christodoulakis A, Aravantinou-Karlatou A, Tsiligianni I. Optimal pathways to lung cancer screening in primary care settings: a scoping review. Curr Oncol. 2024;32(1):8.

Gould MK, Huang BZ, Tammemagi MC, Kinar Y, Shiff R. Machine learning for early lung cancer identification using routine clinical and laboratory data. Am J Respir Crit Care Med. 2021;204(4):445–53.

Article  PubMed  Google Scholar 

US Bureau of Labor Statistics. Consumer price index. 2024. [May 1, 2024]. Available from: https://www.bls.gov/cpi/data.htm.

American Hospital Association. Table 4.4: Aggregate hospital payment-to-cost ratios for private payers, Medicare, and Medicaid, 1995–2018. 2024. [September 24, 2024]. Available from: https://www.aha.org/system/files/2018-05/2018-chartbook-table-4-4.pdf.

Keisler-Starkey K, Bunch LN, Lindstrom RA. Health insurance coverage in the United States: 2022. [December 12, 2025]. Available from: https://www.census.gov/library/publications/2023/demo/p60-281.html.

Centers for Medicare & Medicaid Services. Physician fee schedule. 2024. [December 6, 2024]. Available from: https://www.cms.gov/medicare/payment/fee-schedules/physician.

National Cancer Institute. Surveillance, epidemiology, and end results program. 2024. [May 1, 2024]. Available from: https://seer.cancer.gov/statistics-network/explorer/.

Tindle HA, Stevenson Duncan M, Greevy RA, Vasan RS, Kundu S, Massion PP, et al. Lifetime smoking history and risk of lung cancer: results from the Framingham heart study. J Natl Cancer Inst. 2018;110(11):1201–7.

PubMed  PubMed Central  Google Scholar 

Keisler-Starkey K, Bunch LN. U.S. Census Bureau Current Population Reports, P60-274, Health Insurance Coverage in the United States: 2020. Washington, DC, 2021.

National Cancer Institute. SEER cancer statistics review (CSR) 1975-2015. 2024. [May 1, 2024]. Available from: https://seer.cancer.gov/csr/1975_2015/.

National Cancer Institute. Cancer stat facts: lung and bronchus cancer; 2021. 2021. [May 1, 2024]. Available from: https://seer.cancer.gov/statfacts/html/lungb.html.

Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013;119(22):3976–83.

Article  PubMed  Google Scholar 

Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA. 2016;315(21):2300–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meza R, Jeon J, Toumazis I, Ten Haaf K, Cao P, Bastani M, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA. 2021;325(10):988–97.

Article  PubMed  PubMed Central  Google Scholar 

Richards TB, Soman A, Thomas CC, VanFrank B, Henley SJ, Gallaway MS, et al. Screening for lung cancer—10 states, 2017. MMWR Morb Mortal Wkly Rep. 2020;69(8):201–6.

Article  PubMed  PubMed Central  Google Scholar 

Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med. 2015;162(7):485–91.

Article  PubMed  PubMed Central  Google Scholar 

Henderson LM, Bacchus L, Benefield T, Huamani Velasquez R, Rivera MP. Rates of positive lung cancer screening examinations in academic versus community practice. Transl Lung Cancer Res. 2020;9(4):1528–32.

Article  PubMed  PubMed Central  Google Scholar 

Goshen R, Choman E, Ran A, Muller E, Kariv R, Chodick G, et al. Computer-assisted flagging of individuals at high risk of colorectal cancer in a large health maintenance organization using the ColonFlag test. JCO Clin Cancer Inform. 2018;2:1–8.

Article  PubMed  Google Scholar 

National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.

Article  Google Scholar 

Roth JA, Sullivan SD, Goulart BH, Ravelo A, Sanderson JC, Ramsey SD. Projected clinical, resource use, and fiscal impacts of implementing low-dose computed tomography lung cancer screening in Medicare. J Oncol Pract. 2015;11(4):267–72.

Article  PubMed  PubMed Central  Google Scholar 

Toumazis I, de Nijs K, Cao P, Bastani M, Munshi V, Ten Haaf K, et al. Cost-effectiveness evaluation of the 2021 US Preventive Services Task Force recommendation for lung cancer screening. JAMA Oncol. 2021;7(12):1833–42.

Article  PubMed  Google Scholar 

Toumazis I, Erdogan SA, Bastani M, Leung A, Plevritis SK. A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a diagnostic biomarker. JNCI Cancer Spectr. 2021. https://doi.org/10.1093/jncics/pkab081.

Article  PubMed  PubMed Central  Google Scholar 

Villanti AC, Jiang Y, Abrams DB, Pyenson BS. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One. 2013;8(8):e71379.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Centers for Medicare & Medicaid Services. Physician fee schedule 2022. 2022. [September 23, 2022]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/.

Onal O, Kocer M, Eroglu HN, Yilmaz SD, Eroglu I, Karadogan D. Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer. Turk J Med Sci. 2020;50(8):1838–50.

Article  PubMed  PubMed Central  Google Scholar 

Sheehan DF, Criss SD, Chen Y, Eckel A, Palazzo L, Tramontano AC, et al. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare. Cancer Med. 2019;8(1):94–103.

Article  PubMed